SaintMed Public Company Limited
SaintMed Public Company Limited engages in the importing and distribution of medical equipment to private hospitals, clinics, and the general public in Thailand. It also offers sleep monitoring services, as well as rents medical equipment. The company was founded in 1998 and is based in Bang Bua Thong, Thailand.
SaintMed Public Company Limited (SMD) - Net Assets
Latest net assets as of September 2024: ฿845.87 Million THB
Based on the latest financial reports, SaintMed Public Company Limited (SMD) has net assets worth ฿845.87 Million THB as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿1.24 Billion) and total liabilities (฿396.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿845.87 Million |
| % of Total Assets | 68.09% |
| Annual Growth Rate | 31.05% |
| 5-Year Change | 288.52% |
| 10-Year Change | N/A |
| Growth Volatility | 102.7 |
SaintMed Public Company Limited - Net Assets Trend (2016–2023)
This chart illustrates how SaintMed Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SaintMed Public Company Limited (2016–2023)
The table below shows the annual net assets of SaintMed Public Company Limited from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | ฿900.06 Million | -12.43% |
| 2022-12-31 | ฿1.03 Billion | +14.47% |
| 2021-12-31 | ฿897.86 Million | +300.98% |
| 2020-12-31 | ฿223.91 Million | -3.35% |
| 2019-12-31 | ฿231.66 Million | +21.38% |
| 2018-12-31 | ฿190.87 Million | +25.21% |
| 2017-12-31 | ฿152.44 Million | +12.39% |
| 2016-12-31 | ฿135.64 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SaintMed Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 628.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿413.97 Million | 45.99% |
| Common Stock | ฿112.34 Million | 12.48% |
| Other Comprehensive Income | ฿71.48 Million | 7.94% |
| Other Components | ฿302.27 Million | 33.58% |
| Total Equity | ฿900.06 Million | 100.00% |
SaintMed Public Company Limited Competitors by Market Cap
The table below lists competitors of SaintMed Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sun Peak Metals Corp
OTCQB:SUNPF
|
$11.69 Million |
|
Signal Advance Inc
PINK:SIGL
|
$11.70 Million |
|
Chuang's China Investments Limited
F:CUG
|
$11.70 Million |
|
Apontis Pharma AG
XETRA:APPH
|
$11.70 Million |
|
Jeonjinbio Co. Ltd
KQ:110020
|
$11.69 Million |
|
Enwell Energy plc
PINK:RGPMF
|
$11.68 Million |
|
Seni Jaya Corporation Bhd
KLSE:9431
|
$11.68 Million |
|
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG
|
$11.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SaintMed Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 1,027,763,250 to 900,061,454, a change of -127,701,796 (-12.4%).
- Net income of 79,243,259 contributed positively to equity growth.
- Dividend payments of 145,491,600 reduced retained earnings.
- Share repurchases of 60,245,392 reduced equity.
- Other comprehensive income increased equity by 60,245,392.
- Other factors decreased equity by 61,453,455.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿79.24 Million | +8.8% |
| Dividends Paid | ฿145.49 Million | -16.16% |
| Share Repurchases | ฿60.25 Million | -6.69% |
| Other Comprehensive Income | ฿60.25 Million | +6.69% |
| Other Changes | ฿-61.45 Million | -6.83% |
| Total Change | ฿- | -12.43% |
Book Value vs Market Value Analysis
This analysis compares SaintMed Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.96x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.78x to 0.96x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ฿0.81 | ฿3.86 | x |
| 2017-12-31 | ฿0.68 | ฿3.86 | x |
| 2018-12-31 | ฿0.85 | ฿3.86 | x |
| 2019-12-31 | ฿1.03 | ฿3.86 | x |
| 2020-12-31 | ฿1.00 | ฿3.86 | x |
| 2021-12-31 | ฿4.31 | ฿3.86 | x |
| 2022-12-31 | ฿4.57 | ฿3.86 | x |
| 2023-12-31 | ฿4.02 | ฿3.86 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SaintMed Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.80%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.58%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 1.20x
- Recent ROE (8.80%) is below the historical average (27.01%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 40.21% | 9.66% | 1.19x | 3.49x | ฿40.97 Million |
| 2017 | 25.84% | 8.40% | 1.05x | 2.93x | ฿24.14 Million |
| 2018 | 15.99% | 6.03% | 1.06x | 2.50x | ฿11.43 Million |
| 2019 | 26.09% | 9.77% | 1.36x | 1.97x | ฿37.27 Million |
| 2020 | 34.72% | 11.76% | 1.03x | 2.87x | ฿55.36 Million |
| 2021 | 35.61% | 19.72% | 1.18x | 1.53x | ฿229.90 Million |
| 2022 | 28.86% | 14.76% | 1.66x | 1.18x | ฿193.88 Million |
| 2023 | 8.80% | 9.58% | 0.77x | 1.20x | ฿-10.76 Million |
Industry Comparison
This section compares SaintMed Public Company Limited's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $72,343,839
- Average return on equity (ROE) among peers: 34.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SaintMed Public Company Limited (SMD) | ฿845.87 Million | 40.21% | 0.47x | $11.69 Million |
| E for L Aim Public Company Limited (EFORL) | $-104.57 Million | 0.00% | 0.00x | $13.47 Million |
| Healthlead Public Company Limited (HL) | $124.97 Million | 41.67% | 2.19x | $14.11 Million |
| SEI (SEI) | $28.36 Million | 62.98% | 8.85x | $3.29 Million |
| Techno Medical Public Company Limited (TM) | $222.40 Million | 20.33% | 1.97x | $2.99 Million |
| Winnergy Medical Public Company Limited (WINMED) | $90.56 Million | 49.99% | 2.66x | $3.06 Million |